Literature DB >> 30404870

Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients.

Heather Greenlee1,2,3, Zaixing Shi4, Hanina Hibshoosh3, Dilip D Giri5, Aqeel Ahmed3, Samantha Williams5, Domenick J Falcone6, Lisle A Winston6, Xi K Zhou6, Clifford A Hudis5, Dawn L Hershman3, Andrew J Dannenberg6, Neil M Iyengar5,6.   

Abstract

Breast white adipose tissue inflammation (BWATi) is associated with obesity and higher breast cancer risk among non-Hispanic white women. Obesity is prevalent in Hispanic/Latina patients with breast cancer, and the occurrence of BWATi in this population is not well-characterized. The association between BWATi and body mass index (BMI) was evaluated in Hispanic/Latina patients with breast cancer who underwent mastectomy. BWATi was defined as the presence of crown-like structures of the breast (CLS-B), detected by CD68 IHC in nontumor breast tissue. BWATi severity was quantified as number of CLS-B/cm2 Adipocyte diameter was measured using hematoxylin and eosin-stained breast tissue sections. Preoperative BMI (within 1 week prior to mastectomy) was categorized as normal (18.5-<25.0 kg/m2), overweight (25.0-<30.0 kg/m2), class I obesity (30.0-<35.0 kg/m2), and class II-III obesity (35.0 kg/m2 or above). Patient charts were abstracted to record clinicopathologic features and liver function tests <90 days before mastectomy. The study included 91 women (mean age 69 years; range 36-96 years). Prevalence of BWATi increased with BMI (24% in normal weight, 34% in overweight, 57% in class I obesity, and 65% in class II-III obesity; P trend <0.01). Severe BWATi (>0.27 CLS-B/cm2) was associated with higher BMI (P trend = 0.046) and greater adipocyte diameter (P = 0.04). Adjusting for BMI, neoadjuvant chemotherapy, and elevated alanine aminotransferase were associated with severe BWATi, and current smoking was associated with mild BWATi (all P < 0.05). BWATi was associated with higher BMI in Hispanic/Latina patients with breast cancer, consistent with previously described associations in other populations. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2018        PMID: 30404870      PMCID: PMC6663483          DOI: 10.1158/1940-6207.CAPR-18-0207

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  6 in total

Review 1.  Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti-tumor immunity.

Authors:  Laura M Sipe; Mehdi Chaib; Ajeeth K Pingili; Joseph F Pierre; Liza Makowski
Journal:  Immunol Rev       Date:  2020-05       Impact factor: 12.988

Review 2.  Obesity and Breast Cancer: The Role of Crown-Like Structures in Breast Adipose Tissue in Tumor Progression, Prognosis, and Therapy.

Authors:  Sara Socorro Faria; Luís Henrique Corrêa; Gabriella Simões Heyn; Lívia Pimentel de Sant'Ana; Raquel das Neves Almeida; Kelly Grace Magalhães
Journal:  J Breast Cancer       Date:  2020-05-20       Impact factor: 3.588

3.  Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer.

Authors:  Maret L Maliniak; Aswathy Miriam Cheriyan; Mark E Sherman; Yuan Liu; Keerthi Gogineni; Jiaqi Liu; Jiabei He; Uma Krishnamurti; Jasmine Miller-Kleinhenz; Ryan Ashiqueali; Jinjing He; Rami Yacoub; Lauren E McCullough
Journal:  Breast Cancer Res       Date:  2020-06-17       Impact factor: 6.466

Review 4.  Obesity, Type 2 Diabetes, and Cancer Risk.

Authors:  Tiffany Scully; Abora Ettela; Derek LeRoith; Emily Jane Gallagher
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

Review 5.  Obesity and Energy Balance Considerations in Triple-Negative Breast Cancer.

Authors:  Elizabeth R Berger; Neil M Iyengar
Journal:  Cancer J       Date:  2021 Jan-Feb 01       Impact factor: 3.360

Review 6.  Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer.

Authors:  Maret L Maliniak; Jasmine Miller-Kleinhenz; Deirdre P Cronin-Fenton; Timothy L Lash; Keerthi Gogineni; Emiel A M Janssen; Lauren E McCullough
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.